Hernandez, I., & Gellad, W. F. (2020). Differences Between Managed Care and Fee-for-Service Medicaid in the Use of Generics for High-Rebate Drugs: The Cases of Insulin Glargine and Glatiramer. J Manag Care Spec Pharm.
Citação norma ChicagoHernandez, Inmaculada, and Walid F. Gellad. "Differences Between Managed Care and Fee-for-Service Medicaid in the Use of Generics for High-Rebate Drugs: The Cases of Insulin Glargine and Glatiramer." J Manag Care Spec Pharm 2020.
MLA CitationHernandez, Inmaculada, and Walid F. Gellad. "Differences Between Managed Care and Fee-for-Service Medicaid in the Use of Generics for High-Rebate Drugs: The Cases of Insulin Glargine and Glatiramer." J Manag Care Spec Pharm 2020.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.